About
Gemina Labs
A bio-tools company with a library of proprietary reagents and components that can fundamentally change the rapid in vitro diagnostics sector, especially lateral flow technology.
​
Gemina’s bio-tool library is used to bring high-performance rapid tests to market, with significantly reduced development and production costs.
​
Our team in an immensely experienced group of experts. They are all passionate about making positive changes, impressed with the way that the chemistry works and with a shared enthusiasm for the long term potential of lateral flow technology and its impact on healthcare and wellbeing - worldwide.
Purpose
To supply the healthcare and bioprocessing industries with best-in-class tools and reagents.
Values
Making a significant contribution to the biotechnology industry worldwide, needs the courage to step outside of what is conventional. Our company is a place where global expertise converges and is bound together by mutual respect and trust.
History
The company began operating in May 2020. Our first patent was filed in the September of the same year. Our first prototype was produced in Spring 2021, we were publicly listed in August 2021 and obtained our first product approval in May 2022.
